<DOC>
	<DOCNO>NCT02833805</DOCNO>
	<brief_summary>Our primary objective determine feasible previously untreated severe aplastic anemia ( SAA ) patient transplant use non-myeloablative conditioning post transplantation cyclophosphamide .</brief_summary>
	<brief_title>NMA Haplo MUD BMT Newly Diagnosed Severe Aplastic Anemia</brief_title>
	<detailed_description>This clinical trial upfront bone marrow transplantation patient SAA fully human leukocyte antigen ( HLA ) match donor . The trial use condition regimen successful refractory relapse set maximize engraftment post transplant therapy minimize graft versus host disease ( GVHD ) . This would use patient yet undergone immunosuppressive therapy SAA think unlikely respond immunosuppressive therapy SAA .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Confirmed diagnosis inherit acquire severe aplastic anemia ( SAA ) One follow available donor : 1 . HLAhaploidentical relative 2 . If recipient &gt; = 40 year old , may use HLAmatched related donor 3 . For recipient inherit bone marrow failure syndrome ( IBMFS ) clear evidence disorder potential related donor , may use 10/10 matched unrelated donor Recipient and/or legal guardian must sign protocol inform consent Donor must willing donate bone marrow Left ventricular ejection fraction ( LVEF ) &gt; = 40 % . For recipient &lt; 13 year old , shorten fraction &gt; = 26 % may use instead . Bilirubin &lt; 3 x upper limit normal ( ULN ) age , unless patient Gilbert 's disease aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &lt; 5 x ULN age For patient &gt; = 13 year old : estimate creatinine clearance &gt; 50 mL/min use CockcroftGault formula actual body weight For patient &gt; = 1 &lt; 13 year old : glomerular filtration rate ( GFR ) estimate updated Schwartz formula &gt; = 90 mL/min/1.73 m^2 . If estimate GFR &lt; 90 mL/min/1.73 m^2 , 24hour measure creatinine clearance must &gt; 50 mL/min/1.73 m^2 . For patient &gt; = 8 year old , diffuse capacity lung carbon monoxide ( DLCO ) ( correct hemoglobin ) &gt; 40 % ; force expiratory volume one second ( FEV1 ) &gt; 50 % ; force vital capacity ( FVC ) &gt; 50 % For patient &lt; 8 year old unable undergo pulmonary function testing : evidence dyspnea rest ; need supplemental oxygen ; oxygen saturation &gt; 92 % room air Karnofsky/Lansky status ( depend age ) &gt; = 70 % Females males childbearing potential must agree practice 2 effective method contraception time . If unwilling , must agree complete abstinence . Previous administration immunosuppressive therapy SAA . Fanconi anemia . At minimum , diagnosis must exclude diepoxybutane ( DEB ) equivalent test peripheral blood marrow patient &lt; 30 year old . Clonal cytogenetic abnormality consistent premyelodysplastic syndrome ( preMDS ) MDS bone marrow examination Presence antidonor antibody Prior allogeneic stem cell transplant Prior solid organ transplant Uncontrolled bacterial , viral , fungal infection HIV seropositivity Active hepatitis B C infection determine serology and/or nucleic acid testing ( NAT ) Pregnancy active breastfeeding Prior malignancy except : resect basal carcinoma treat cervical carcinoma situ ; cancer treat curative intent &gt; 5 year previously . Other prior cancer allow unless approve PI .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>immunosuppression</keyword>
	<keyword>nonmyeloablative</keyword>
	<keyword>non-myeloablative</keyword>
	<keyword>allogeneic</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>bone marrow</keyword>
	<keyword>bone marrow transplant</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>thymoglobulin</keyword>
	<keyword>ATG</keyword>
	<keyword>fludarabine</keyword>
</DOC>